News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
68,659 Results
Type
Article (1929)
Company Profile (1)
Press Release (66729)
Section
Business (21546)
Career Advice (9)
Deals (4564)
Drug Development (8182)
FDA (1806)
Job Trends (806)
News (37116)
Policy (3566)
Tag
Academia (91)
Africa (78)
Alliances (8097)
Alzheimer's disease (107)
Approvals (1806)
Artificial intelligence (3)
Asia (20992)
Australia (2452)
Bankruptcy (8)
Best Places to Work (570)
Biosimilars (6)
Biotechnology (5)
Breast cancer (7)
C2C Services and Suppliers (6434)
California (131)
Canada (129)
Cancer (62)
Career advice (9)
Cell therapy (5)
China (46)
Clinical research (6817)
Collaboration (17)
Colorado (3)
Compensation (3)
Connecticut (5)
COVID-19 (177)
Data (48)
Diabetes (5)
Diagnostics (574)
Drug discovery (3)
Duchenne muscular dystrophy (5)
Earnings (7419)
Europe (12150)
Events (6762)
Executive appointments (13)
FDA (1845)
Florida (7)
Funding (16)
GLP-1 (33)
Government (233)
Healthcare (1068)
Hotbed/Location (30155)
Illinois (6)
India (4)
Infectious disease (178)
Inflammatory bowel disease (12)
IPO (1598)
Japan (14)
Job creations (242)
Job search strategy (9)
Kansas (5)
Layoffs (6)
Legal (944)
Liver cancer (14)
Lung cancer (11)
Maine (4)
Manufacturing (5)
Maryland (48)
Massachusetts (103)
Medical device (1106)
Medtech (1107)
Mergers & acquisitions (2985)
Metabolic disorders (13)
Minnesota (18)
Neuroscience (122)
New Jersey (55)
New York (60)
NextGen Class of 2024 (221)
Non-profit (61)
North Carolina (40)
Northern California (73)
Obesity (5)
Pancreatic cancer (3)
Parkinson's disease (7)
Patents (6)
Pennsylvania (18)
People (4919)
Phase I (1846)
Phase II (2842)
Phase III (2601)
Pipeline (20)
Postmarket research (241)
Preclinical (639)
Radiopharmaceuticals (21)
Rare diseases (9)
Real estate (600)
Regulatory (2488)
Reports (6)
Research institute (91)
Schizophrenia (3)
Series A (5)
South America (106)
Southern California (44)
Startups (426)
Supply chain (3)
Texas (7)
United States (527)
Utah (4)
Vaccines (9)
Virginia (4)
Date
Last 7 days (58)
Last 30 days (228)
Last 365 days (3521)
2024 (2608)
2023 (3829)
2022 (7024)
2021 (6396)
2020 (5885)
2019 (3878)
2018 (3014)
2017 (3572)
2016 (3185)
2015 (4051)
2014 (3033)
2013 (2604)
2012 (2784)
2011 (2923)
2010 (2675)
68,659 Results for "engeneic pty ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
EnGeneIC Selects Global CDMO BioCina to Advance Their Ground-Breaking Cancer Treatment
September 25, 2024
·
3 min read
Press Releases
Halia Therapeutics Joins Forces with Southern Star Research Pty Ltd to Advance Clinical Development of Novel LRRK2 Inhibitor, HT-4253 for Neurodegenerative Diseases
September 3, 2024
·
4 min read
Business
EnGeneIC and Singapore Institute of Advanced Medicine Holdings Forge Strategic Partnership to Revolutionise Cancer Treatment in Asia
EnGeneIC, a clinical-stage biopharmaceutical company pioneering the development of a First-in-Class targeted nanocell for cancer therapy has announced strategic partnerships with Singapore Institute of Advanced Medicine Holdings and Singapore Medical Incorporation.
June 6, 2024
·
3 min read
Press Releases
Distinguished Oncologist, Professor Daniel Von Hoff joins the Scientific/Clinical Advisory Board of EnGeneIC Cancer Therapeutics
October 2, 2024
·
3 min read
Genetown
enGene to Present at the Jefferies Global Healthcare Conference
enGene Holdings Inc. today announced that Jason Hanson, Chief Executive Officer, will present a corporate overview at the Jefferies Global Healthcare Conference in New York City, on June 5, 2024, at 12:30 p.m. ET.
May 29, 2024
·
1 min read
Business
enGene Reports First Quarter 2024 Financial Results and Recent Corporate Progress
enGene Holdings Inc. (Nasdaq: ENGN or “enGene” or the “Company”) today announced its financial results for the first quarter ended January 31, 2024.
March 11, 2024
·
9 min read
Press Releases
enGene Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
October 1, 2024
·
2 min read
Business
enGene Reports Third Quarter 2024 Financial Results and Provides a Business Update
September 10, 2024
·
7 min read
Business
enGene Announces the Election of Paul Hastings and Wouter Joustra to its Board of Directors
enGene Holdings Inc., a clinical-stage genetic medicines company whose non-viral lead program EG-70 is in a pivotal study for BCG-unresponsive non-muscle invasive bladder cancer, announced the election of Paul Hastings and Wouter Joustra as new members of its Board of Directors at the Company’s 2024 annual meeting of shareholders.
May 15, 2024
·
8 min read
enGene To Present at the Leerink Partners Global Biopharma Conference
enGene Holdings Inc. announced that Jason Hanson, Chief Executive Officer, will present at the Leerink Partners Global Biopharma Conference in Miami, FL on March 13, 2024, at 8:40 a.m. ET.
March 5, 2024
·
1 min read
1 of 6,866
Next
